๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Updated clinical pharmacologic considerations for HIV-1 protease inhibitors

โœ Scribed by Peter L. Anderson; Courtney V. Fletcher

Book ID
107540601
Publisher
Springer
Year
2004
Tongue
English
Weight
364 KB
Volume
1
Category
Article
ISSN
1548-3568

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

[Advances in Pharmacology] HIV-1: Molecu
[Advances in Pharmacology] HIV-1: Molecular Biology and Pathogenesis Volume 56 || HIVโ€1 Integrase Inhibitors: Update and Perspectives
โœ Semenova, Elena A. ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier ๐ŸŒ English โš– 28 KB

Although it is one of the most-widely studied viruses, many mysteries still remain about HIV. Covering the latest advances and challenges associated with clinical application of new antiviral drugs and vaccines, this revised edition is a companion to Murad:*HIV-1: Molecular Biology and Pathogenesis,

Structure-activity relationships for mac
Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 protease
โœ G. Abbenante; D.A. Bergman; R.I. Brinkworth; D.R. March; R.C. Reid; P.A. Hunt; I ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 261 KB

A series of appended macrocycles were synthesized and tested as inhibitors of HIV-1 protease (HIV PR). The macrocycle structurally mimics an N-terminal tripeptide component of peptide substrates. Structure-activity relationships explore steric limitations to the size and shape of the substituents an